143 related articles for article (PubMed ID: 20446229)
1. Acute respiratory distress due to antipsychotic drugs.
Yagmur F; Ulusoy HB; Buyukoglan H; Kaya MG
Pharmacopsychiatry; 2010 May; 43(3):118-9. PubMed ID: 20446229
[No Abstract] [Full Text] [Related]
2. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
3. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
Yoshida K; Higuchi H; Hishikawa Y
Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
[TBL] [Abstract][Full Text] [Related]
4. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
5. Risperidone-Induced Acute Respiratory Distress in an Adolescent with Autism.
Chen F
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):851-852. PubMed ID: 27220113
[No Abstract] [Full Text] [Related]
6. Schizophrenia.
McIntosh A; Lawrie S
Clin Evid; 2004 Dec; (12):1502-33. PubMed ID: 15865730
[No Abstract] [Full Text] [Related]
7. Risperidone-induced Pisa syndrome.
Harada K; Sasaki N; Ikeda H; Nakano N; Ozawa H; Saito T
J Clin Psychiatry; 2002 Feb; 63(2):166. PubMed ID: 11874220
[No Abstract] [Full Text] [Related]
8. Schizophrenia.
Nadeem Z; McIntosh A; Lawrie S
Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
[No Abstract] [Full Text] [Related]
9. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
10. Management of a risperidone-induced tardive Pisa syndrome: a case report.
Kaufmann A; Boesch S; Fleischhacker WW; Hofer A
J Clin Psychopharmacol; 2012 Jun; 32(3):418-20. PubMed ID: 22561474
[No Abstract] [Full Text] [Related]
11. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
Meibach RC
Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
[No Abstract] [Full Text] [Related]
12. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
[No Abstract] [Full Text] [Related]
13. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW
J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420
[TBL] [Abstract][Full Text] [Related]
14. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
Blazer DG
Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
[No Abstract] [Full Text] [Related]
15. Angioneurotic edema with risperidone: a case report and review of literature.
Soumya RN; Grover S; Dutt A; Gaur N
Gen Hosp Psychiatry; 2010; 32(6):646.e1-3. PubMed ID: 21112458
[TBL] [Abstract][Full Text] [Related]
16. Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
Takaki M; Mizuki Y; Miki T
J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E14. PubMed ID: 24763772
[No Abstract] [Full Text] [Related]
17. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
[TBL] [Abstract][Full Text] [Related]
18. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
Dittert S; Soyka M; Winter C; Möller HJ
Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
[No Abstract] [Full Text] [Related]
19. A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.
Chan HY; Chang CJ; Chiang SC; Chen JJ; Chen CH; Sun HJ; Hwu HG; Lai MS
J Psychopharmacol; 2010 Jan; 24(1):91-8. PubMed ID: 18801830
[TBL] [Abstract][Full Text] [Related]
20. A patient with haloperidol induced laryngeal dystonia.
Peek DF
Acta Anaesthesiol Belg; 2008; 59(2):103-5. PubMed ID: 18652109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
